BOSTON--(BUSINESS WIRE)--Jun. 3, 2016--
Flex Pharma, Inc. (NASDAQ: FLKS) today announced that it will present a
corporate overview at the following upcoming investor conferences in
The Jefferies 2016 Healthcare Conference on June 9, 2016 at 11:30 a.m.
in New York, NY;
The 36th Annual Piper Jaffray Consumer Conference on June
15, 2016 at 10:50 a.m. in New York, NY;
The JMP Securities 2016 Life Sciences Conference on June 21, 2016 at
9:00 a.m. in New York, NY; and
The 3rd Annual ROTH Healthcare Day on June 22, 2016 in
A live webcast of Flex Pharma’s presentations at these conferences may
be accessed in the Investor section of the Company’s website at www.flex-pharma.com.
Please log on to the Flex Pharma website approximately 15 minutes prior
to the scheduled webcast to ensure adequate time for any software
downloads that may be required. A replay of the webcast will be
available on Flex Pharma’s website for 2 weeks following each
About Flex Pharma
Flex Pharma, Inc. is a biotechnology company that is developing
innovative and proprietary treatments for nocturnal leg cramps, cramps
and spasms associated with severe neuromuscular conditions such as MS
and ALS, and exercise-associated muscle cramps. Flex Pharma was founded
by National Academy of Science members Rod MacKinnon, M.D. (2003 Nobel
Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of
ion channels and neurobiology, along with Chair and CEO Christoph
Westphal, M.D., Ph.D.
Visit www.TeamHOTSHOT.com for
updates and to learn more about HOTSHOT™, the Company’s consumer
product which is scientifically proven to prevent and treat muscle
HOTSHOT is a consumer product that is marketed to endurance athletes.
HOTSHOT complements the Company’s drug development business and is not
intended to diagnose, treat, cure or prevent any disease.
Follow Flex Pharma (@flexpharma) and HOTSHOTTM (@Team_HOTSHOT) on
View source version on businesswire.com: http://www.businesswire.com/news/home/20160603005169/en/
Source: Flex Pharma, Inc.
Flex Pharma, Inc.
Elizabeth Woo, 617-874-1829
Relations & Corporate Communications